Recent Updates
Recently added Catalysts
ATYR Positive Sentiment

Wayne A.I. Frederick, M.D.

Key Takeaway: Wayne A.I. Frederick, M.D., recently concluded his tenure as President of Howard University, where he served from 2014 to 2023. He is a prominent cancer surgeon and professor, recognized for his research on healthcare disparities. Dr. Frederick holds multiple degrees and has held various leadership roles in academia and healthcare organizations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Frederick's extensive experience in cancer surgery.
  • His commitment to addressing healthcare disparities.
  • Recognition as a leader in medical education and research.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
5.7%
average across 7 past catalysts
Cash runway
~18 mo
Low dilution risk
Lead asset
Efzofitimod/kg
Phase 3 · Pulmonary Sarcoidosis

Full Press Release Details

Wayne A.I. Frederick, M.D., is the President Emeritus of Howard University, having previously served as the 17th President from July 2014 – September 2023. He is also the distinguished Charles R. Drew Professor of Surgery at the Howard University College of Medicine and a practicing cancer surgeon at Howard University Hospital. Dr. Frederick earned a B.S., M.D., and completed his surgical residency training at Howard University Hospital . Following his postdoctoral research and surgical oncology fellowships at the University of Texas MD Anderson Cancer Center, Dr. Frederick was Associate Director of the Cancer Center at the University of Connecticut. Upon his return to Howard University, his academic positions included Associate Dean in the College of Medicine, Division Chief in the Department of Surgery, Director of the Cancer Center and Deputy Provost for Health Sciences. He also earned an M.B.A. degree from Howard University’s School of Business. Dr. Frederick is the author of numerous peer-reviewed articles, book chapters, abstracts, and editorials and is a widely recognized expert on disparities in healthcare and medical education. His medical research focuses on narrowing racial, ethnic and gender disparities in cancer-care outcomes. Dr. Frederick is a fellow of the American College of Surgeons (ACS) and belongs to numerous surgical and medical organizations, including the ACS’ Academy of Master Surgeon Educators, the American Surgical Association and the National Academy of Medicine. Dr. Frederick also serves on the Board of Directors of Humana, Inc., Agostini Limited, Insulet Corporation, Workday, Inc., Mutual of America Life Insurance Co., and the American Cancer Society, in addition to a few other privately held companies and charitable organizations.

Frequently Asked Questions

What roles did Dr. Frederick hold at Howard University?

Dr. Frederick served as the 17th President and held various academic positions.

What is Dr. Frederick's area of expertise?

He is recognized for his work in cancer surgery and healthcare disparities.

Where did Dr. Frederick complete his surgical training?

He completed his residency at Howard University Hospital and fellowships at MD Anderson.

What organizations is Dr. Frederick affiliated with?

He is a fellow of the American College of Surgeons and serves on multiple boards.

Last updated: Jan 17, 2024